Paxman AB (publ)
Paxman AB (publ) (PXMBF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Paxman AB (publ) (PXMBF), covering cash flow, earnings, and balance sheets.
Paxman AB (publ) (PXMBF) Income Statement & Financial Overview
Explore comprehensive income reports for Paxman AB (publ) PXMBF, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $67.13M | $66.15M | $64.82M | $63.41M |
Cost of Revenue | $22.60M | $20.09M | $20.66M | $52.81M |
Gross Profit | $44.53M | $46.06M | $44.16M | $10.60M |
Gross Profit Ratio | $0.66 | $0.70 | $0.68 | $0.17 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $18.40M | $18.83M | $17.25M | $16.88M |
Operating Expenses | $38.33M | $39.06M | $35.67M | $34.10M |
Total Costs & Expenses | $60.93M | $59.15M | $56.33M | $52.81M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $11.72M | $316000.00 | $3.44M | $763000.00 |
Depreciation & Amortization | $4.18M | $4.46M | $3.26M | $4.17M |
EBITDA | $10.38M | $18.26M | $11.76M | $14.77M |
EBITDA Ratio | $0.15 | $0.28 | $0.18 | $0.23 |
Operating Income | $6.20M | $7.003M | $8.50M | $10.60M |
Operating Income Ratio | $0.09 | $0.11 | $0.13 | $0.17 |
Other Income/Expenses (Net) | -$11.73M | $6.48M | -$3.44M | -$763000.00 |
Income Before Tax | -$5.53M | $13.49M | $5.06M | $9.84M |
Income Before Tax Ratio | -$0.08 | $0.20 | $0.08 | $0.16 |
Income Tax Expense | -$17000.00 | $1.30M | $65000.00 | $21000.00 |
Net Income | -$5.51M | $12.18M | $5.00M | $9.82M |
Net Income Ratio | -$0.08 | $0.18 | $0.08 | $0.15 |
EPS | -$0.29 | $0.64 | $0.26 | $0.52 |
Diluted EPS | -$0.29 | $0.64 | $0.26 | $0.51 |
Weighted Avg Shares Outstanding | $19.25M | $19.01M | $19.01M | $19.01M |
Weighted Avg Shares Outstanding (Diluted) | $19.32M | $19.08M | $19.08M | $19.08M |
Financial performance has remained strong, with revenue growing from $63.41M in Q2 2024 to $67.13M in Q1 2025. Gross profit continued to perform well, with margins at 66% in the latest quarter. Operating income reached $6.20M in Q1 2025, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $10.38M. Net income dropped to -$5.51M, keeping EPS at -$0.29. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan